FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Substantially Equivalent 510(k) Device Information

horizontal rule

Applicant: One Lambda, Inc., Canoga Park, CA
510(k) number: BK980015
Product: FlowPRA
Date: 7/23/99

horizontal rule

Summary of Safety and Effectiveness

APRIL 21, 1998

Claiming equivalence to:
Lambda Cell Tray - BK840013

Description of the Device
The FlowPRA Screening Test is designed for flow cytometric screening of panel reactive antibody (PRA) against HLA using a panel of FlowPRA beads, which are microparticles (2-4µm in diameter) coated with purified HLA antigens.

Intended Use
The FlowPRA Screening Test is intended for use in flow cytometric detection of HLA-specific antibodies in serum.

Summary of Substantial equivalence
FlowPRA and LCT is intended to detect the presence of HLA antibodies in a serum sample. The mechanism for attachment is the same. The HLA antibody will attach to the complementary antigen of a HLA specificity. In the case of the FlowPRA the HLA antigen is attached to the bead and in the case of the LCT the antigen is attached to the lymphocyte. The detection method is different. FlowPRA will detect the attached antibody with the use of a Flow Cytometer and the LCT by use of the microcytotoxicity test. The data received in both cases will be used to calculate the % PRA for the serum sample.

The methodology of detecting the HLA antigen and antibody attachment is different but the ending results are the same, % PRA.

Summary of Intended Use as compared to the predicate device
The FlowPRA Screening Test has the same name intended us as the Lambda Cell Tray (LCT) which is to determine the presence of HLA antibodies in human serum. Both tests have 30 cells (bead) panel. Both tests can determine the percent PRA (%PRA). Studies showed a good correlation between the two tests on the % PRA detected from randomly selected patient sera.

Summary of Comparison between FlowPRA and LCT
Comparison of the FlowPRA test to the marketed LCT tests is listed in Table 1 And 2 which showed R values of over 80%.

Summary of Technological Characteristics
The technology of FlowPRA utilizes flow cytometry based technique for HLA antibodies detection and obtains statistically similar results as the predicted device LCT. This test utilizes a flow cytometer for data analysis. We have compared different flow cytometers in different laboratories which all gives comparable results.

 

 
horizontal rule